Viewing Study NCT05999292


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2025-12-27 @ 1:33 AM
Study NCT ID: NCT05999292
Status: TERMINATED
Last Update Posted: 2024-12-09
First Post: 2023-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of 68Ga-R8760
Sponsor: Radionetics Oncology
Organization:

Study Overview

Official Title: Phase 1 Safety and Dosimetry Study of 68Ga-R8760 in Patients With Adrenocortical Carcinoma and Healthy Volunteers
Status: TERMINATED
Status Verified Date: 2024-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Sponsor decision
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A Phase 1 Safety and Dosimetry Study of 68Ga-R8760 in Patients with Adrenocortical Carcinoma and Healthy Volunteers
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: